Cystic fibrosis patients on triple-drug therapy can safely reduce daily lung treatments
A new multi-site study led by researchers at CU Anschutz shows that people with cystic fibrosis (CF) who…
Blocking immune cell signals reduces scar tissue formation in wounds
Researchers at the University of Arizona uncovered a previously unknown population of circulating immune cells that play a…
Study advances the possibility of age-based pancreatic cancer treatment
While some risk factors for cancer can be mitigated through lifestyle choices such as diet or exercise, aging…
New insights reveal how TCF and LEF proteins control Wnt signaling and disease progression
Researchers have unveiled the intricate molecular mechanisms governing TCF/LEF-mediated transcription in the canonical Wnt pathway, identifying these proteins…
New biofilm discovery may pave way to undermining antibiotic-resistant Pseudomonas
The bacterium known as Pseudomonas aeruginosa is an unwelcome visitor in the human body. Serious infections can result…
New gene-editing method can correct many disease-causing mutations in mammalian cells
Some genetic disorders-such as cystic fibrosis, hemophilia and Tay Sachs disease-involve many mutations in a person’s genome, often…
Nanoparticles offer new hope for treating alcohol-related liver disease
Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease…
Antihypertensive and lipid-lowering drugs show efficacy against steatotic liver disease
Metabolic dysfunction-associated steatotic liver disease is the most common liver disease in the world, affecting about one third…
AI toolset reveals links between lung fibrosis and aging
A new research paper was published in Volume 17, Issue 8 of Aging-US on August 8, 2025, titled “AI-driven toolset for…
Antibody Treatment Could Block Gut-Derived Toxin Behind Kidney Fibrosis
A newly identified bacterial molecule called corisin appears to travel from the gut to the kidneys, triggering inflammation…
CHI3L1 emerges as a powerful biomarker for liver disease diagnosis and management
The identification of Chitinase-3-like protein 1 (CHI3L1) as a crucial biomarker in liver disease is revolutionizing how clinicians…
Kiwi family move to Australia to get cystic fibrosis drug Trikafta for daughter
Adalyn Delaney was suffering the effects of CF before she was even born, with health staff discovering during…